Predictors of hospital re-admissions among Hispanics with hepatitis C-related cirrhosis

Pradeep R Atla1, Muhammad Y Sheikh1, Firdose Gill2

  • 1Division of Gastroenterology, Hepatology and Nutrition, University of California San Francisco, Fresno MEP (Pradeep R. Atla, Muhammad Y. Sheikh, Rabindra Kundu, Jayanta Choudhury), Fresno, California, USA.

Insights

Hospital readmissions for decompensated cirrhosis are common, especially among Hispanics with hepatitis C virus (HCV)-related cirrhosis. Alcohol use, hepatic encephalopathy (HE), varices, and advanced Child-Turcotte-Pugh (CTP) class predict readmissions in this population.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Public Health

Background:

  • Hospital readmissions in decompensated cirrhosis worsen patient outcomes.
  • Hispanics face a high burden of hepatitis C virus (HCV)-related liver disease.
  • Understanding readmission factors in this demographic is crucial for improving care.

Purpose of the Study:

  • To identify factors contributing to hospital readmission rates.
  • To focus on Hispanic patients with HCV-related cirrhosis.
  • To inform targeted interventions for reducing readmissions.

Main Methods:

  • Retrospective review of 292 HCV-related cirrhosis admissions (2009-2012).
  • Compared Hispanic (n=189) and non-Hispanic (n=103) patient data.
  • Used logistic regression to determine predictors of hospital readmissions.

Main Results:

  • Hispanics constituted 71% of the 132 cirrhosis-related readmissions.
  • Hepatic encephalopathy (HE) and variceal hemorrhage were primary readmission causes.
  • Predictors for readmission in Hispanics included alcohol use, HE, varices, and advanced Child-Turcotte-Pugh (CTP) class.

Conclusions:

  • Advanced CTP class (B and C) is a major predictor of readmission in Hispanics with HCV-related cirrhosis.
  • HE and variceal hemorrhage are the main drivers of these readmissions.
  • Identifying these factors can guide strategies to reduce hospital readmissions.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
309
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
723
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
768
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
320